KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Illumina (ILMN) Research & Development (2016 - 2025)

Illumina's Research & Development history spans 17 years, with the latest figure at $239.0 million for Q4 2025.

  • For Q4 2025, Research & Development fell 6.64% year-over-year to $239.0 million; the TTM value through Dec 2025 reached $967.0 million, down 17.56%, while the annual FY2025 figure was $967.0 million, 17.28% down from the prior year.
  • Research & Development reached $239.0 million in Q4 2025 per ILMN's latest filing, up from $229.0 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $486.0 million in Q1 2023 to a low of $197.0 million in Q2 2021.
  • Average Research & Development over 5 years is $299.5 million, with a median of $319.0 million recorded in 2022.
  • Peak YoY movement for Research & Development: soared 153.49% in 2021, then dropped 29.84% in 2023.
  • A 5-year view of Research & Development shows it stood at $436.0 million in 2021, then fell by 25.46% to $325.0 million in 2022, then increased by 4.92% to $341.0 million in 2023, then fell by 24.93% to $256.0 million in 2024, then decreased by 6.64% to $239.0 million in 2025.
  • Per Business Quant, the three most recent readings for ILMN's Research & Development are $239.0 million (Q4 2025), $229.0 million (Q3 2025), and $247.0 million (Q2 2025).